N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosylceramide

Term ID

CHEBI:27499

Synonyms

(2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl 3-O-(5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl)-beta-D-galactopyranoside
(2S,3R,4E)-2-alkanamido-3-hydroxyoctadec-4-en-1-yl 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranoside
(Gal)1 (Neu5Ac)1 (Cer)1
alpha-Neu5Ac-(2->3)-beta-D-Gal-(1<->1')-Cer
alpha-Neup5Ac-(2->3)-beta-D-Galp-(1<->1')-Cer
ganglioside GM4
N-Acetylneuraminyl-galactosylceramide
NeuAcalpha2-3Galbeta-Cer
NeuAcalpha2->3Gal-Cer

Definition

A sialomonoglycosylceramide having N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosyl as the sialomonoglycosyl component.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: sialomonoglycosylceramide

sialomonoglycosylceramide Show first 5 Terms
has_role: mouse metabolite

mouse metabolite Show first 5 Terms
inverse is_conjugate_base_of: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosylceramide(1-)

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosylceramide(1-) Show first 5 Terms
is_conjugate_acid_of: N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosylceramide(1-)

N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosylceramide(1-) Show first 5 Terms

Phenotype

Phenotype resulting from N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosylceramide

Phenotype where environments contain N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosylceramide

Phenotype modified by environments containing N-acetyl-alpha-neuraminosyl-(2->3)-beta-D-galactosylceramide

Human Disease Model